|
| |
CephalonCephalon seeks to discover, develop and market innovative products to treat neurological and sleep disorders, cancer, and pain. The company is committed to providing patients and the medical community with novel therapies to treat unmet medical conditions through its proprietary research programs and by acquiring promising products for clinical development and commercial sale.
| Contact Details: |
| 41 Moores Road |
| Frazer |
| PA |
| 19355 |
| United States of America |
| Tel: | 610-344-0200 |
| Fax: | 215 344 0065 |
| Email: | cmerritt@cephalon.com |
| WWW: | www.Cephalon.com/
|
|
Loading...
|
Recent Publications by Cephalon: |  |
Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice.
RATIONALE: Lithium and several antiepileptic drugs have mood-stabilizing... | 17th November, 2009
| CNS Biology, Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine
| Psychopharmacology (Berl). 2009 Aug;205(3):369-77. Epub 2009 Apr 29.
DOI Direct Link |
Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies.
BACKGROUND AND OBJECTIVE: Armodafinil, a non-amphetamine,... | 23rd October, 2009
| Clinical Pharmacology Department, Cephalon, Inc., Frazer, Pennsylvania
| Clin Drug Investig. 2009;29(9):613-23. doi:
DOI Direct Link |
Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification.
The relatively high background matrix in in vivo samples typically poses... | 21st October, 2009
| Covance Laboratories Inc., 3301 Kinsman Boulevard, Madison, WI 53704-2523,
| Rapid Commun Mass Spectrom. 2009 Sep;23(18):3003-12.
DOI Direct Link |
Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities.
Dimebolin (Dimebon), is a non-selective antihistamine approved in Russia... | 20th October, 2009
| World Wide Discovery Research, Cephalon, Inc., 145 Brandywine Parkway,
| Biochem Pharmacol. 2009 Oct 15;78(8):1035-42. Epub 2009 Jun 21.
DOI Direct Link |
Detection of low level histamine H3 receptor occupancy by autoradiography.
Histamine H(3) receptor antagonists have been proposed as a novel approach... | 22nd September, 2009
| World Wide Discovery Research, Cephalon, Inc., West Chester, PA 19380,
| J Neurosci Methods. 2009 Dec 15;185(1):70-5. Epub 2009 Sep 16.
DOI Direct Link |
→View more Cephalon research publications. |
Press Releases on Cephalon:
|
 |
| Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting |
24th November, 2009 |
Ambit Biosciences Corporation |
SAN DIEGO, Nov. 24 /PRNewswire/ -- Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the
|
| Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis |
23rd November, 2009 |
Cephalon, Inc. |
MALVERN, Pa. and FRAZER, Pa., Nov. 23 /PRNewswire-FirstCall/ -- Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. (Nasdaq: CEPH) today announced results from a
|
| Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group |
20th November, 2009 |
Cell Therapeutics, Inc. |
SEATTLE, Nov. 20 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled
|
| The Cancer Pain Drug Market, Driven by the Continued Dominance of Opioids, Will Increase From $2.3 Billion in 2008 to $3.7 Billion in 2018 |
17th November, 2009 |
Decision Resources |
WALTHAM, Mass., Nov. 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, driven by the continued
|
| Nielsen Announces 2009 Winners of the First-Ever CLIO Healthcare Awards |
16th November, 2009 |
The Nielsen Company |
NEW YORK, Nov. 16 /PRNewswire/ -- The Nielsen Company, a leading global information and media company and the CLIO Awards, one of the world's most recognized international advertising and design
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 41 individuals from Cephalon using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 1086 times since April 2007, the link to the organisation's website has been followed 157 times Recent Search Terms used to find this page: cephalon brandywine | preparation of Dimebolin hydrochloride patent | cephalon | Cephalon fax | dimebolin half life | Dimebolin | 5ht6 receptor 2009 | dimebolin 5-ht6 | cephalon mail fax | patents for dimebolin | . Search for more companies in Frazer Search for more companies in PA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Cephalon |
